title: Letters to the editors.
authors.forename: Rebecca L
authors.initials: RL
authors.lastname: Angerstein
authors.forename: Louis
authors.initials: L
authors.lastname: Lemberg
authors.forename: Kathyrn Buchanan
authors.initials: KB
authors.lastname: Keller
mesh_terms: D000806:Angiotensin-Converting Enzyme Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use; D008078:Cholesterol, LDL / Q000097:blood; D004232:Diuretics / Q000008:administration & dosage / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D004656:Enalapril / Q000008:administration & dosage / Q000627:therapeutic use; D019317:Evidence-Based Medicine; D006333:Heart Failure / Q000188:drug therapy*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use; D014481:United States
chemical_list: D000806:Angiotensin-Converting Enzyme Inhibitors; D008078:Cholesterol, LDL; D004232:Diuretics; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D004656:Enalapril